Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014935 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014936 |
| CAS No | NA |
| Mol.F. | C30H40N6O3S |
| Mol.Wt. | 564.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014937 |
| CAS No | NA |
| Mol.F. | C30H40N6O3S |
| Mol.Wt. | 564.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014938 |
| CAS No | NA |
| Mol.F. | C30H39N7O4S |
| Mol.Wt. | 593.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014939 |
| CAS No | NA |
| Mol.F. | C19H28N4O3S |
| Mol.Wt. | 392.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014940 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014941 |
| CAS No | NA |
| Mol.F. | C11H16N4O3S |
| Mol.Wt. | 284.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014942 |
| CAS No | NA |
| Mol.F. | C17H24N4O3S |
| Mol.Wt. | 364.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014943 |
| CAS No | NA |
| Mol.F. | C16H21N5O4S |
| Mol.Wt. | 379.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014944 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014945 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014946 |
| CAS No | NA |
| Mol.F. | C45H40N6O3 |
| Mol.Wt. | 712.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014947 |
| CAS No | NA |
| Mol.F. | C39H36N6O3 |
| Mol.Wt. | 636.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014948 |
| CAS No | NA |
| Mol.F. | C20H21N3O3 |
| Mol.Wt. | 351.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014949 |
| CAS No | NA |
| Mol.F. | C24H28N6O4 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014950 |
| CAS No | NA |
| Mol.F. | C24H28N6O4 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |